[Federal Register Volume 77, Number 226 (Friday, November 23, 2012)]
[Notices]
[Page 70188]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-28486]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application;
Cayman Chemical Company
Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal
Regulations (CFR), this is notice that on September 25, 2012, Cayman
Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108,
made application to the Drug Enforcement Administration (DEA) to be
registered as a bulk manufacturer of the following basic classes of
controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
JWH-250 (6250)............................. I
SR-18 also known as RCS-8 (7008)........... I
JWH-019 (7019)............................. I
JWH-081 (7081)............................. I
SR-19 also known as RCS-4 (7104)........... I
JWH-122 (7122)............................. I
AM-2201 (7201)............................. I
JWH-203 (7203)............................. I
2C-T-2 (7385).............................. I
JWH-398 (7398)............................. I
Psilocybin (7437).......................... I
Psilocyn (7438)............................ I
2C-D (7508)................................ I
2C-E (7509)................................ I
2C-H (7517)................................ I
2C-I (7518)................................ I
2C-C (7519)................................ I
2C-N (7521)................................ I
2C-P (7524)................................ I
2C-T-4 (7532).............................. I
AM-694 (7694).............................. I
Phenylacetone (8501)....................... I
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for distribution to their research and forensics customers conducting
drug testing and analysis.
Any other such applicant, and any person who is presently
registered with DEA to manufacture such substances, may file comments
or objections to the issuance of the proposed registration pursuant to
21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), 8701
Morrissette Drive, Springfield, Virginia 22152; and must be filed no
later than January 22, 2013.
Dated: November 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-28486 Filed 11-21-12; 8:45 am]
BILLING CODE 4410-09-P